novo glp-1 drug Details of failed studies cast pall on Nordisk's as Alzheimer's treatment GLP-1s for Alzheimer's: Novo Nordisk
Description
Waser B, Blank A, Karamitopoulou E, Perren A, Reubi JC
In a 10-year randomized trial, sleeve gastrectomy resulted in good and sustainable weight loss over a full decade
Cardoso, P
7 (2010): 16741685, 10.2337/dc10-0666
This medication may also cause nausea, vomiting, and diarrhea
As demand for GLP-1 therapies expands, balancing injection frequency, sustainability and drug stability is becoming increasingly important
